CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations.
Author
Alexander William Wyatt
Arkhjamil Angeles
+9Â more
Arshia Beigi
Daniel Khalaf
Evan W Warner
Gillian Rae Vandekerkhove
Kasmintan A Schrader
Katherine Sunderland
Kim N. Chi
Matti Annala
Steven Yip
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase 2 randomized cross-over trial of abiraterone + prednisone (ABI+P) vs enzalutamide (ENZ) for patients (pts) with metastatic castration resistant prostate cancer (mCPRC): Results for 2nd-line therapy.
Author
Alexander William Wyatt
Conrad D. Oja
+10Â more
Daniel Khalaf
Daygen L. Finch
Gillian Rae Vandekerkhove
Joanna Vergidis
Katherine Sunderland
Kevin Beja
Kim N. Chi
Martin Gleave
Matti Annala
Muhammad Zulfiqar
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref